节点文献
新型冠状病毒肺炎疫情期间新生儿遗传代谢性疾病筛查专家共识
Consensus for Newborn Screening of Inherited Metabolic Disorders during the Coronavirus Disease 2019 Epidemic
【摘要】 2019年底出现的新型冠状病毒(2019-nCoV)感染在全国多地及世界各国陆续发生,至今尚未完全控制,已有儿童甚至新生儿感染的报道,中国每年约1 500万新生儿出生,需要进行遗传代谢性疾病新生儿筛查,存在潜在风险。结合现状,重庆医科大学附属儿童医院新生儿疾病筛查中心联合国家卫生健康委员会临床检验中心新生儿疾病筛查室间质评专业委员会的部分专家,经过讨论,提出新型冠状病毒肺炎(COVID-19)疫情期间新生儿遗传代谢性疾病的筛查、诊治及随访的系统建议。
【Abstract】 The 2019 novel coronavirus(2019-nCoV) infection that emerged at the end of 2019 has been occurring in many places and countries all over the world, and has not yet been fully controlled, with infections in children and even newborns having been reported. Approximately 15 million newborns are born each year in China, and there is a potential risk of newborn screening for inherited metabolic disorders. Based on the current status, some experts from the newborn screening center of Children’s Hospital of Chongqing Medical University and Clinical Laboratory Center of National Health Commission formulate the contingency suggestion for screening, diagnosis, treatment and follow-up of newborn screening of inherited metabolic disorders during the coronavirus disease 2019(COVID-2019) epidemic.
【Key words】 2019 novel coronavirus; neonates; disease screening; inherited metabolic disorders;
- 【文献出处】 儿科药学杂志 ,Journal of Pediatric Pharmacy , 编辑部邮箱 ,2021年10期
- 【分类号】R722.1
- 【下载频次】261